United States Organ-On-Chip Market is expected to reach US$ 940.4 Million by 2032 | Top key players - Emulate, Inc., MIMETAS B.V., Valo Health.

Market Size and Growth:

The Global Organ-On-Chip Market Size reached US$ 165.98 million in 2024 and is expected to reach US$ 1,956.28 million by 2032, growing with a CAGR of 36.12% during the forecast period 2025-2032. The Market is growing due to rising demand for advanced drug testing platforms and increasing adoption of microphysiological systems in pharmaceutical and biotech research. According to DataM Intelligence

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/organ-on-chip-market?sz

The Organ-On-Chip Market involves the development, manufacturing, and application of microfluidic devices that mimic human organ functions for drug testing, disease modeling, and personalized medicine. These chips integrate living cells with sensors to replicate physiological responses, reducing reliance on animal testing, accelerating drug development, and enhancing precision in biomedical research and pharmaceutical testing globally.

Industry Recent Developments: United States

✅ November 2025: Regulatory acceptance from agencies such as the FDA is boosting industry adoption of Organ-On-Chip technology, supported by validation studies demonstrating predictive equivalence with clinical outcomes.

✅ October 2025: The U.S. market is advancing with biotech innovation, and increased FDA validation programs alongside pharmaceutical adoption, making North America the largest market in Organ-On-Chip.

✅ September 2025: Researchers at The Ohio State University developed a "ventilator on a chip" to study lung damage, enabling real-time detection of lung damage at the cellular level.

Industry Recent Developments: Japan

✅ November 2025: Japan maintains dominance in the Asia-Pacific Organ-On-Chip market with a well-established healthcare system focusing on microfluidics, regenerative medicine, and tissue engineering.

✅ October 2025: Japan continues to benefit from growing government support for advancement in healthcare technologies, driving further growth in the Organ-On-Chip market.

✅ September 2025: Japan shows significant efforts in microphysiological systems development with government-backed initiatives and advancements in Organ-On-Chip technology, reflecting the country's focus on innovation in this field.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/organ-on-chip-market?sz

Key FDA / Regulatory Developments (2025):

FDA Roadmap to Phase Out Animal Testing:

✅ The FDA has laid out a roadmap to reduce reliance on animal testing in preclinical drug development, with organ‐on‐chip systems playing a "central role."

✅ This shift is aligned with broader "new approach methodologies" (NAMs), including microphysiological systems like OoCs and in silico (AI) models.

✅ The move is expected to streamline drug development by allowing submissions based on non-animal-based safety data.

ISTAND Pilot Program - Emulate Liver‐Chip:

✅ Emulate's Liver‐Chip (S1) was accepted into the FDA's ISTAND Pilot Program - making it the first Organ‐Chip to get this distinction.

✅ Through this program, Emulate is working with FDA to qualify the Liver‐Chip for use in IND submissions, particularly for predicting drug-induced liver injury (DILI).

GAO Report & Regulatory Support for NAMs:

✅ A 2025 GAO (Government Accountability Office) report underscores growing regulatory support for non-animal models, including human organ-on-chip systems.

✅ The report signals a shift from exploratory research toward more formal regulatory adoption, easing the pathway for OoC data to be accepted in drug approval processes.

FDA Multi-Year Research Collaboration:

✅ The FDA earlier entered into a multi-year R&D collaboration to evaluate organ‐chip technologies (miniaturized human organ systems on micro-engineered chips) for studying pharmacology, toxicity, disease mechanisms, etc.

Mergers, Acquisitions, and Strategic Partnerships (2025):

OrganOx Acquisition by Terumo:

✅ In a major deal, Terumo (Japanese medical device firm) acquired OrganOx (UK-based) for about US$ 1.5 billion. OrganOx's technology preserves organs (e.g., liver) and is used in transplantation settings.

Emulate - Novo Nordisk Strategic Partnership:

✅ Emulate entered a co-development agreement with Novo Nordisk to build OoC-based assays for diabetes drug discovery and safety profiling.

CN Bio - Pharmaron Partnership:

✅ CN Bio (which makes the PhysioMimix OoC platform) has partnered with Pharmaron to validate its technology and integrate it within Pharmaron's R&D workflows, especially for safety testing and drug development.

Mimetas Expansion:

✅ MIMETAS (OrganoPlate platform provider) is reportedly expanding manufacturing reach via acquisitions to scale up its chip production (according to market‐report sources).

Funding for OrganOx:

✅ Earlier in 2025, OrganOx raised US$ 142 million for U.S. expansion, underscoring strong investor confidence in its OoC‐adjacent technology.

Major Key Players:

1. Emulate, Inc. - Develops organ-on-chip systems that mimic human organ functions for drug testing and disease research, enhancing preclinical testing accuracy.

2. MIMETAS B.V. - Specializes in microfluidic organ-on-chip platforms, offering high-throughput models for pharmaceutical and toxicology studies.

3. Valo Health - Uses AI-driven platforms and organ-on-chip technology to accelerate drug discovery and optimize clinical development.

4. Nortis, Inc. - Provides microfluidic and organ-on-chip solutions for modeling human tissues, focusing on kidney, vascular, and cancer research.

5. AxoSim - Offers human-based nerve-on-chip and cardiac-on-chip systems to support neuropharmacology and cardiac safety testing.

6. BICO - The Bio Convergence Company - Integrates bioprinting, organ-on-chip, and tissue engineering technologies to advance drug development and regenerative medicine.

Segments Covered in the Organ-On-Chip Market:

By Products & ServiceLive: Products, Services.

By Application: Drug Discovery, Toxicology Research, Otherrs.

By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others.

Regional Analysis for Organ-On-Chip Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=organ-on-chip-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Organ-On-Chip market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Organ-On-Chip Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Organ-On-Chip market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Organ-On-Chip Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Organ-On-Chip market?

➠ Who are the global key manufacturers of the Organ-On-Chip Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Organ-On-Chip market opportunities and threats faced by the vendors in the global Organ-On-Chip Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Organ-On-Chip market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.